Although the regulation of p27 in normal cells occurs at the transcriptional, translational, and post-translational levels [13–18], most attention in cancer cells has focused on p27 misregulation via ubiquitin-dependent protein degradation, specifically by the SCF-Skp2 E3 ubiquitin-protein ligase [19]. Here, CDKN1B is linked to cancer.